GoodRx Holdings, Inc.

Informe acción NasdaqGS:GDRX

Capitalización de mercado: US$2.8b

GoodRx Holdings Dirección

Dirección controles de criterios 2/4

El CEO de GoodRx Holdings' es Scott Wagner , nombrado en Apr 2023, tiene una permanencia de 1.08 años. compensación anual total es $10.14M, compuesta por 5% salario y 95% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.049% de las acciones de la empresa, por valor de $1.30M. La antigüedad media del equipo directivo y de la junta directiva es de 3 años y 8.3 años, respectivamente.

Información clave

Scott Wagner

Chief Executive Officer (CEO)

US$10.1m

Compensación total

Porcentaje del salario del CEO5.0%
Permanencia del CEO1.1yrs
Participación del CEO0.05%
Permanencia media de la dirección3yrs
Promedio de permanencia en la Junta Directiva8.3yrs

Actualizaciones recientes de la dirección

Recent updates

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

Nov 02
GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

GoodRx laying off 140 employees, 16% of workforce

Aug 31

GoodRx: Trending Positive, But Not A Buy Yet

Aug 25

GoodRx: Unexpected Short Squeeze As Grocer Issue Resolved

Aug 09

GoodRx: Unexpected Wrench Pushes Me To The Sidelines

Jul 25

Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

Jul 20
Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

GoodRx: Guidance Gets Worse, Stay Clear

May 19

GoodRx: Time To Buy The Dip

Apr 23

Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

Apr 19
Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Scott Wagner en comparación con los beneficios de GoodRx Holdings?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023US$10mUS$512k

-US$9m

Compensación vs. Mercado: La compensación total de Scott($USD10.14M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.65M).

Compensación vs. Ingresos: Insufficient data to compare Scott's compensation with company performance.


CEO

Scott Wagner (52 yo)

1.1yrs

Permanencia

US$10,144,526

Compensación

Mr. Scott W. Wagner serves as Interim Chief Executive Officer at GoodRx Holdings, Inc. since April 25, 2023 and serves as its Principal Operating Officer since February 15, 2024. He serves as Head of Strat...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Trevor Bezdek
Co-founder & Chairman of the Board12.7yrsUS$811.53k1.37%
$ 38.7m
Scott Wagner
Interim CEO & Principal Operating Officer1.1yrsUS$10.14m0.049%
$ 1.4m
Douglas Hirsch
Co-founder12.7yrsUS$784.86k1.37%
$ 38.7m
Karsten Voermann
Chief Financial Officer4.2yrsUS$902.24k0.057%
$ 1.6m
Romin Nabiey
Chief Accounting Officer2.1yrsUS$2.58m0.031%
$ 886.1k
Bansi Nagji
President of Healthcare3.9yrsUS$4.91m0.066%
$ 1.9m
Mike Walsh
President & Executive VP of Prescription Marketplaceless than a yearsin datossin datos
Whitney Notaro
Vice President of Investor Relationsno datasin datossin datos
Gracye Cheng
General Counsel & Secretaryno datasin datossin datos
Andrew Slutsky
Chief Marketing Officerless than a yearUS$864.80k0%
$ 0
Vina Leite
Chief People Officer2yrssin datossin datos
Justin Fengler
Senior Vice President of Corporate Strategy & Business Operations8.3yrssin datossin datos

3.0yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: GDRX's management team is considered experienced (3 years average tenure).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Trevor Bezdek
Co-founder & Chairman of the Board12.7yrsUS$811.53k1.37%
$ 38.7m
Douglas Hirsch
Co-founder12.7yrsUS$784.86k1.37%
$ 38.7m
Gregory Mondre
Independent Director5.6yrssin datossin datos
Dipanjan Deb
Independent Director8.6yrssin datossin datos
Agnes Rey-Giraud
Independent Director7.9yrsUS$269.53k0.069%
$ 2.0m
Julie M. Bradley
Independent Director3.8yrsUS$272.53k0.015%
$ 422.1k
Christopher Adams
Independent Director8.6yrssin datossin datos
Kelly Kennedy
Independent Directorless than a yearUS$448.63ksin datos

8.3yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: GDRX's board of directors are considered experienced (8.3 years average tenure).